The theory that the COVID-19 pandemic was sparked by the escape of a virus from a Chinese laboratory increased tensions between Washington and Beijing. It also raised questions about the possibility of the U.S. funding for bat coronavirus research at the lab being put in the middle of the controversy.
U.S. Senator Rand Paul has repeatedly accused the National Institute of Allergy and Infectious Diseases (NIAID) director, Anthony Fauci of lying about the country's financing of gain-of-function research that enhanced bat viruses at the Wuhan Institute of Virology, suggesting that Fauci has been complicit since the beginning of the pandemic.
Paul implied that Fauci misled the Congress during his testimony in May, where he said that the U.S. never funded a gain-of-function project at the institute. Paul said that Fauci stated that the NIH never and does not now fund gain-of-function research, yet it was done entirely in the Wuhan institute with funds from the NIH.
However, records show that the grant, which was first awarded in 2015 and renewed in 2020, went to EcoHealth Alliance, "a global environmental health nonprofit organization dedicated to protecting wildlife and public health from the emergence of disease."
The project aimed to include characterizing coronaviruses present in the populations of southern China, and conducting surveillance to detect spillover events of such viruses to people.
Renz and Garner also speak about the comparisons of the tyranny in handling COVID-19 to Hitler and the Nazis, saying that those who opposed stay-at-home requirements early in the pandemic charged state officials with behaving like Hitler and imposing Nazi-style orders, where "non-essential workers got put on a train" to be killed.
In this same sense, Garner noted that the government is saying the unvaccinated individuals are carriers of the COVID-19 disease, but this is not necessarily true, as many vaccinated individuals are still carrying breakthrough variants of the virus.
Use of COVID-19 vaccine for children can be dangerous
One area of concern for Garner is the emergency use of COVID-19 vaccines for children 12 to 15 years of age, which can be dangerous, considering the adverse effects that the vaccines can have on adults.
The FDA approval could also mean big changes in terms of vaccine requirements for students and workers. At least five routine childhood vaccines have been previously required for children attending school or childcare, and those shots have been fully approved by the FDA.
Hemi Tewarson, executive director of the National Academy for State Health Policy said that the COVID-19 vaccine is a little different from others because of the way that it was developed.
The Pfizer-BioNTech COVID-19 vaccine is now available for children ages 12 and older in the United States, but the company said that it expects to have trial data on children ages 5 to 11 by the end of September, and have those vaccines authorized for the younger ages shortly after. They are also looking into vaccines for children as young as two years old.
All these are concerning for Garner, who says that the dangerous jab tore her up, knowing that it is a depopulation agenda that the people are facing. Whether for children or for adults, taking the vaccine is a risk for people who may experience adverse effects, whether they are children or adults. (Related: CovidVaccineVictims.com documents heartbreaking stories of vaccine injures, deaths.
Through her organization, New Mexico Stands Up!, Garner is working with fellow lawyers to protect the rights of individuals through public interest legal action and to provide additional support to people who are facing the loss of health freedom due to the dangerous vaccine mandates that the Biden administration is pushing for.
Listen to Tom Renz's and Ana Garner's conversation about the COVID-19 virus, vaccines, and possible legal actions to stop the government from suppressing medical freedom at "Lawfare with Tom Renz," Tuesdays at 11:30 a.m. on Brighteon.TV.
Sources include:
Please contact us for more information.
